Oric Pharmaceuticals Inc
NASDAQ:ORIC
Oric Pharmaceuticals Inc
NASDAQ:ORIC
Price:
11.16
USD
0.54%
Market Closed
Market Cap:
$1.1B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Oric Pharmaceuticals Inc
NASDAQ:ORIC
|
US |
|
Livesense Inc
TSE:6054
|
JP |
|
Grand Ocean Advanced Resources Co Ltd
HKEX:65
|
HK |
|
Granite Real Estate Investment Trust
TSX:GRT.UN
|
CA |
|
Sharecare Inc
NASDAQ:SHCR
|
US |
|
Canara Bank Ltd
BSE:532483
|
IN |
|
Northrop Grumman Corp
NYSE:NOC
|
US |
|
Hyosung TNC Corp
KRX:298020
|
KR |
|
La Francaise des Jeux SA
PAR:FDJ
|
FR |
|
EKF Diagnostics Holdings PLC
LSE:EKF
|
UK |
|
I
|
Iniziative Bresciane Inbre SpA
MIL:IB
|
IT |
|
C
|
CNPC Capital Co Ltd
SZSE:000617
|
CN |
|
Hitech Group Australia Ltd
ASX:HIT
|
AU |
|
Hanwha Solutions Corp
KRX:009830
|
KR |
|
Eagle Mountain Mining Ltd
ASX:EM2
|
AU |
|
J
|
Joinn Laboratories China Co Ltd
SSE:603127
|
CN |
|
VL E-Governance & IT Solutions Ltd
BSE:543958
|
IN |
|
SSP Group PLC
LSE:SSPG
|
UK |
|
National Vision Holdings Inc
NASDAQ:EYE
|
US |
|
Eucatex SA Industria e Comercio
BOVESPA:EUCA4
|
BR |
|
A
|
Arrow Exploration Corp
LSE:AXL
|
CA |
|
K
|
Kub Malaysia Bhd
KLSE:KUB
|
MY |
|
P
|
Parker-Hannifin Corp
LSE:0KFZ
|
US |
|
P
|
PPAP Automotive Ltd
NSE:PPAP
|
IN |
Relative Value
The Relative Value of one
ORIC
stock under the Base Case scenario is
hidden
USD.
Compared to the current market price of 11.16 USD,
Oric Pharmaceuticals Inc
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
ORIC Relative Value
HIDDEN
Multiples Across Competitors
ORIC Competitors Multiples
Oric Pharmaceuticals Inc Competitors
Oric Pharmaceuticals Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Oric Pharmaceuticals Inc
NASDAQ:ORIC
|
1.1B USD | 0 | -8.5 | -6 | -6 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
362.5B USD | 5.9 | 86.6 | 14.4 | 20 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
187.5B USD | 5.1 | 24.3 | 14.1 | 14.1 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
170.3B USD | 5.8 | 20 | 12.5 | 15.5 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
115.3B USD | 9.6 | 29.2 | 21.9 | 22.9 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
77.5B USD | 5.4 | 17.2 | 12.6 | 14.4 | |
| AU |
|
CSL Ltd
ASX:CSL
|
66.8B AUD | 3.1 | 34.3 | 11.3 | 14.3 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 | |
| US |
|
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
41.3B USD | 11.1 | 131.9 | 73.8 | 82 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
